Pfizer Pipeline
Pfizer Pipeline Snapshot 4 Pipeline represents progress of R&D programs as of October 27, 2015 Included are 56 NMEs, 20 additional indications, plus 8 biosimilars
Download Pfizer Pipeline
Information
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
Advertisement
Documents from same domain
NARDIL - Pfizer
www.pfizer.com1 NARDIL® (Phenelzine Sulfate Tablets, USP) Suicidality and Antidepressant Drugs Antidepressants increased the risk compared to placebo of suicidal thinking and behavior
MATERIAL SAFETY DATA SHEET - Pfizer
www.pfizer.commaterial safety data sheet _____ 5. fire fighting measures
Sheet, Data, Safety, Material, Material safety data sheet, Pfizer
MATERIAL SAFETY DATA SHEET - Pfizer
www.pfizer.commaterial safety data sheet _____ 7. handling and storage
Sheet, Data, Safety, Material, Material safety data sheet, Pfizer
MATERIAL SAFETY DATA SHEET - Pfizer
www.pfizer.comMATERIAL SAFETY DATA SHEET _____ Measures for Cleaning / Collecting: Contain the source of spill if it is safe to do so.
Sheet, Data, Safety, Material, Material safety data sheet, Pfizer
PFIZER FACTS The Burden of Cancer in Asia
www.pfizer.comTheburdenofcancerinAsia I n2002,4.2millionnewcancercases—39%ofnewcasesworldwide—werediagnosedamong …
Pfizer Pipeline
www.pfizer.comPfizer Pipeline Snapshot 4 Pipeline represents progress of R&D programs as of January 31, 2017 Included are 62 NMEs, 26 additional indications, plus 8 biosimilars
MATERIAL SAFETY DATA SHEET - Pfizer
www.pfizer.commaterial safety data sheet _____ 2. hazards identification
Sheet, Data, Safety, Material, Material safety data sheet, Pfizer
USPI medroxyprogesterone acetate - Depo …
www.pfizer.com1 Depo-Provera® medroxyprogesterone acetate injectable suspension, USP DESCRIPTION DEPO-PROVERA Sterile Aqueous Suspension contains medroxyprogesterone acetate,
Acetate, Uspi medroxyprogesterone acetate depo, Uspi, Medroxyprogesterone, Depo, Medroxyprogesterone acetate
Patient Information About - Pfizer
www.pfizer.comPatient Information About depo-subQ provera 104™ medroxyprogesterone acetate injectable suspension 104 mg/0.65 mL WHAT IS THE MOST IMPORTANT INFORMATION I SHOULD
Information, Patients, About, Pfizer, Depo, Patient information about, Patient information about depo
Pfizer Inc 100 Route 206 North Peapack, NJ 07977 …
www.pfizer.comApril 13, 2015 Pfizer Inc 100 Route 206 North Peapack, NJ 07977 Email: pfizerinjectables@pfizer.com Global Established Pharmaceuticals Depo®-Testosterone (testosterone cypionate injection, USP) CIII
Pharmaceutical, Global, Email, North, Pfizer, Established, Depo, North peapack, Peapack, Nj 07977, 07977, Nj 07977 email, Com global established pharmaceuticals depo
Related documents
ERYTECH to Present Two Posters at AACR
erytech.com1 ERYTECH to Present Two Posters at AACR PRESS RELEASE Lyon (France), March 17, 2016 – ERYTECH (Euronext Paris: FR0011471135 - ERYP), a French biopharmaceutical company developing innovative ‘tumor starvation’ treatments for acute leukemia and
Poster, Present, Arca, Erytech to present two posters at aacr, Erytech
Chemotherapy Sequencing Guide – For therapies given on …
sites.mckesson.comBevacizumab Bleomycin Carboplatin Cisplatin Cyclophosphamide Cytarabine Dacarbazine Docetaxel Doxorubicin Epirubicin Etoposide Fludarabine Fluorouracil Gemcitabine ...
Guide, Sequencing, Therapies, Chemotherapy, Chemotherapy sequencing guide for therapies
ALT-803 - Altor BioScience
www.altorbioscience.comJune 2016 Potency against Solid and Hematological Tumors in Preclinical Studies: In various solid and hematological tumor models, ALT-803 exhibits impressive, durable anti-tumor activity as a …
NEW ZEALAND DATA SHEET - Medsafe
www.medsafe.govt.nzNEW ZEALAND DATA SHEET 1. PRODUCT NAME SUTENT (sunitinib 12.5mg capsules) SUTENT (sunitinib 25 mg capsules) SUTENT (sunitinib 37.5 mg capsules)
Merck Pipeline - Merck.com | Homepage
www.merck.comPhase 2 Phase 2 Phase 3 Phase 3 Phase 3 Cancer Advanced solid tumors Cutaneous Squamous Cell Carcinoma Diabetes mellitus Ovarian MK Prostate
MEDICARE HOSPICE CRITERIA
www.nhhpco.orgRev.10/11 MEDICARE HOSPICE CRITERIA (condensed for quick reference; final decisions require physician judgment and full LCDs) Need Part I OR (Part II + Part III)
Evaluation of Cutaneous Skin Rash in Subjects Treated with ...
www.mpmmedicalinc.comEvaluation of Cutaneous Skin Rash in Subjects Treated with Regenecare™ Topical Gel (Collagen, Aloe vera, & 2% Lidocaine) During Erbitux® and Combination Therapies for Cancer